Tredan O, Corset V, Wang Q, et al. Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfilER Study. J Clin Oncol. 35, 2017 (suppl; abstr LBA100).
Eigenschappen PET-tracers onderzocht: meerwaarde klinische toepassing 18F-FES bij ER+ mammacarcinoom
jan 2024 | Borstkanker